These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35579809)

  • 1. Industry Perspective on Artificial Intelligence/Machine Learning in Pharmacovigilance.
    Kassekert R; Grabowski N; Lorenz D; Schaffer C; Kempf D; Roy P; Kjoersvik O; Saldana G; ElShal S
    Drug Saf; 2022 May; 45(5):439-448. PubMed ID: 35579809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automation Opportunities in Pharmacovigilance: An Industry Survey.
    Ghosh R; Kempf D; Pufko A; Barrios Martinez LF; Davis CM; Sethi S
    Pharmaceut Med; 2020 Feb; 34(1):7-18. PubMed ID: 32036574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validating Intelligent Automation Systems in Pharmacovigilance: Insights from Good Manufacturing Practices.
    Huysentruyt K; Kjoersvik O; Dobracki P; Savage E; Mishalov E; Cherry M; Leonard E; Taylor R; Patel B; Abatemarco D
    Drug Saf; 2021 Mar; 44(3):261-272. PubMed ID: 33523400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Training Augmented Intelligent Capabilities for Pharmacovigilance: Applying Deep-learning Approaches to Individual Case Safety Report Processing.
    Abatemarco D; Perera S; Bao SH; Desai S; Assuncao B; Tetarenko N; Danysz K; Mockute R; Widdowson M; Fornarotto N; Beauchamp S; Cicirello S; Mingle E
    Pharmaceut Med; 2018; 32(6):391-401. PubMed ID: 30546259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?
    Pariente A; Micallef J; Lahouegue A; Molimard M; Auffret M; Chouchana L; Denis B; Faillie JL; Grandvuillemin A; Letinier L; Pierron E; Pons C; Pujade I; Rubino H; Salvo F
    Therapie; 2023; 78(1):131-143. PubMed ID: 36572627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial Intelligence, Real-World Automation and the Safety of Medicines.
    Bate A; Hobbiger SF
    Drug Saf; 2021 Feb; 44(2):125-132. PubMed ID: 33026641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature.
    Salas M; Petracek J; Yalamanchili P; Aimer O; Kasthuril D; Dhingra S; Junaid T; Bostic T
    Pharmaceut Med; 2022 Oct; 36(5):295-306. PubMed ID: 35904529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilizing Advanced Technologies to Augment Pharmacovigilance Systems: Challenges and Opportunities.
    Lewis DJ; McCallum JF
    Ther Innov Regul Sci; 2020 Jul; 54(4):888-899. PubMed ID: 32557311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automation and artificial intelligence in filamentous fungi-based bioprocesses: A review.
    Wainaina S; Taherzadeh MJ
    Bioresour Technol; 2023 Feb; 369():128421. PubMed ID: 36462761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automation With Intelligence in Drug Research.
    Tu H; Lin Z; Lee K
    Clin Ther; 2019 Nov; 41(11):2436-2444. PubMed ID: 31582192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey.
    Stergiopoulos S; Fehrle M; Caubel P; Tan L; Jebson L
    Pharmaceut Med; 2019 Dec; 33(6):499-510. PubMed ID: 31933240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intelligent Telehealth in Pharmacovigilance: A Future Perspective.
    Edrees H; Song W; Syrowatka A; Simona A; Amato MG; Bates DW
    Drug Saf; 2022 May; 45(5):449-458. PubMed ID: 35579810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review.
    Kompa B; Hakim JB; Palepu A; Kompa KG; Smith M; Bain PA; Woloszynek S; Painter JL; Bate A; Beam AL
    Drug Saf; 2022 May; 45(5):477-491. PubMed ID: 35579812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovation in Pharmacovigilance: Use of Artificial Intelligence in Adverse Event Case Processing.
    Schmider J; Kumar K; LaForest C; Swankoski B; Naim K; Caubel PM
    Clin Pharmacol Ther; 2019 Apr; 105(4):954-961. PubMed ID: 30303528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial Intelligence in Pharmacovigilance: Scoping Points to Consider.
    Hauben M; Hartford CG
    Clin Ther; 2021 Feb; 43(2):372-379. PubMed ID: 33478803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trust in AI: why we should be designing for APPROPRIATE reliance.
    Benda NC; Novak LL; Reale C; Ancker JS
    J Am Med Inform Assoc; 2021 Dec; 29(1):207-212. PubMed ID: 34725693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will the future of pharmacovigilance be more automated?
    Salvo F; Micallef J; Lahouegue A; Chouchana L; Létinier L; Faillie JL; Pariente A
    Expert Opin Drug Saf; 2023; 22(7):541-548. PubMed ID: 37435796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial Intelligence and the Future of the Drug Safety Professional.
    Danysz K; Cicirello S; Mingle E; Assuncao B; Tetarenko N; Mockute R; Abatemarco D; Widdowson M; Desai S
    Drug Saf; 2019 Apr; 42(4):491-497. PubMed ID: 30343417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual Case Safety Report Replication: An Analysis of Case Reporting Transmission Networks.
    van Stekelenborg J; Kara V; Haack R; Vogel U; Garg A; Krupp M; Gofman K; Dreyfus B; Hauben M; Bate A
    Drug Saf; 2023 Jan; 46(1):39-52. PubMed ID: 36565374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data.
    Martin GL; Jouganous J; Savidan R; Bellec A; Goehrs C; Benkebil M; Miremont G; Micallef J; Salvo F; Pariente A; Létinier L;
    Drug Saf; 2022 May; 45(5):535-548. PubMed ID: 35579816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.